Actinium Pharmaceuticals, Inc. (ATNM) - NYSEMKT
  • Alexander Valtsev | Send Message 29 Jun

    Actinium Moves Iomab-B Into Phase 3: http://bit.ly/290616ATNM $ATNM
    Reply
      • Jason Napodano, CFA | Send Message 29 Jun

        $ATNM - Actinium Moves Iomab-B Into Phase 3 >> http://tinyurl.com/hlyp2ju
        Reply
          • Life Sciences Report | Send Message 8 Jun

            " $ATNM's clinical programs offer a cheap long opportunity for investors interested in AML therapeutics"-Fein. More:http://ow.ly/LOKG3013V8y
            Reply
              • Alexander Valtsev | Send Message 2 Jun

                Actinium Plans Phase 2 Trial With Actimab-A, Odds Of Success Look Good: http://bit.ly/020616ATNM $ATNM
                Reply
                  • Jason Napodano, CFA | Send Message 2 Jun

                    My article on $ATNM >> http://bit.ly/1TY6xqF // Are they the next $CPXX ?? #AML
                    Reply
                      • Alexander Valtsev | Send Message 20 Apr

                        Phase 3 For Iomab-B Should Unlock Significant Value At Actinium Pharma: http://bit.ly/200416ATNM $ATNM
                        Reply
                          • Jason Napodano, CFA | Send Message 20 Apr

                            Article on $ATNM >> http://bit.ly/240GMKK
                            Reply (2)
                            • groningentrading | Send Message 27 Apr
                              : Hi Jason, only 0,38% of the stock is held by insiders, what are your thoughts on that?
                            • Jason Napodano, CFA | Send Message 27 Apr
                              : I should be more, clearly.
                              • wilkinson99 | Send Message 30 Mar

                                Premarket Top % Gainers: $ACAD 22% $XTNT $VICL $NETE $ATNM $LINEQ $LNCO $ICLD Losers: $VRNT -14% $CTRV $OPK $OREX $DV $FORM $YANG $EDZ $NUGT
                                Reply
                                  • wilkinson99 | Send Message 30 Mar

                                    Premarket Top % Gainers: $ACAD 30%, $LINEQ 11%, $ATNM 10%, $SUNEQ 8%, $YINN 5%, $BBL 3%, $RIO $RUSL $STO $BP $SHAK $TS $BHP $UWTI $FCAU $XIV
                                    Reply
                                      • Jason Napodano, CFA | Send Message 28 Mar

                                        Update on $ATNM AML programs following $CPXX impressive AML data two weeks ago >> http://bit.ly/1Rohphu
                                        Reply
                                          Company Description
                                          Actinium Pharmaceuticals, Inc. operates as a biopharmaceutical company developing targeted payload immunotherapeutic for the treatment of advanced cancers. The company's targeted radiotherapy products are based on its proprietary delivery platform for the therapeutic utilization of... More
                                          Sector: Healthcare
                                          Industry: Biotechnology
                                          Country: United States